InvestorsHub Logo
Followers 6
Posts 1142
Boards Moderated 0
Alias Born 08/24/2012

Re: Biobillionair post# 12679

Friday, 08/16/2013 3:09:01 PM

Friday, August 16, 2013 3:09:01 PM

Post# of 430647
I'm not debating the CHD or if equivalents increases it. I'm saying label will not be for treating CHD or its equivalents. Vascepa will treat lab lipid values only. The restriction is that the patients must have both CHD (or equivalents) and lipid abnormalities to be on label, but it's not treating CHD,if that occurs fine, but wait for reduce-it for that label
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News